SECIS–SBP2 interactions dictate selenocysteine incorporation efficiency and selenoprotein hierarchy
Low, Susan C., Grundner-Culemann, Elisabeth, Harney, John W., Berry, Marla J.
Selenocysteine incorporation at UGA codons requires cis-acting mRNA secondary structures and several specialized trans-acting factors. The latter include a selenocysteine-specific tRNA, an elongation...
Bitonti, Alan J., Dumont, Jennifer A., Low, Susan C., Peters, Robert T., Kropp, Keith E., Palombella, Vito J., ...
Administration of therapeutic proteins by methods other than injection is limited, in part, by inefficient penetration of epithelial barriers. Therefore, unique approaches to breaching these barriers...
SECIS–SBP2 interactions dictate selenocysteine incorporation efficiency and selenoprotein hierarchy
Low, Susan C., Grundner-Culemann, Elisabeth, Harney, John W., Berry, Marla J.
Selenocysteine incorporation at UGA codons requires cis-acting mRNA secondary structures and several specialized trans-acting factors. The latter include a selenocysteine-specific tRNA, an elongation...
Bitonti, Alan J., Dumont, Jennifer A., Low, Susan C., Peters, Robert T., Kropp, Keith E., Palombella, Vito J., ...
Administration of therapeutic proteins by methods other than injection is limited, in part, by inefficient penetration of epithelial barriers. Therefore, unique approaches to breaching these barriers...
Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn
Mezo, Adam R., McDonnell, Kevin A., Hehir, Cristina A. Tan, Low, Susan C., Palombella, Vito J., Stattel, James M., ...
The neonatal Fc receptor FcRn provides IgG molecules with their characteristically long half-lives in vivo by protecting them from intracellular catabolism and then returning them to the...